Register Log-in Investor Type

Woodford Patient Capital Trust releases full year results to 31 December 2017

Woodford Patient Capital Trust releases full year results to 31 December 2017 – Woodford Patient Capital Trust (WPCT) announced its audited financial report for the year ended 31 December 2017.

The Company’s NAV declined from 93.24p to 91.73p or by -2.0% on a total return basis during the year under review. The share price fell by 7.2% on the same basis.

In the report, the investment manager picked out Proton Partners, which started to treat its first patient in its Newport centre and Benevolent AI, which received $115m of additional funding to reach a valuation of c. $2bn as positive contributors to performance. Oxford Nanopore was also mentioned as a positive contributor, raising a further £100m to be valued at $1.5bn.

 

WPCT : Woodford Patient Capital Trust releases full year results to 31 December 2017

Leave a Reply

Your email address will not be published. Required fields are marked *

Please review our cookie, privacy & data protection and terms and conditions policies and, if you accept, please select your place of residence and whether you are a private or professional investor.

You live in…

You are a…